Key Facts - Endometrial Cancer Awareness Month
- Abdominal Cancers Alliance
- Jun 2
- 1 min read
Updated: Jun 23
Did you know June is Endometrial Cancer Awareness Month? Join us in learning more this month.
Did you know:
1️⃣ Endometrial cancers are the most common gynecologic malignancy in the United States and are largely hormonally driven.
2️⃣ Endometrial cancers are categorized into low-risk and high-risk groups based on histology, stage, and grade. This categorization is based on the surgical pathology and molecular analysis of the tumor and will guide treatment decisions and prognosis.
3️⃣ The main treatment for endometrial cancer is surgery, which will include a hysterectomy (a removal of the uterus) and usually a bilateral salpingo-oophorectomy (removal of both the fallopian tubes and ovaries), and lymph node sampling. Other complementary therapies include radiation, systemic chemotherapy, immunotherapy, and hormone therapy.
4️⃣ With recent evidence demonstrating a significant survival benefit, there has been a shift away from palliative systemic chemotherapy and towards cytoreductive surgery (CRS) as the primary treatment option for patients with metastatic endometrial cancer. The survival benefit is greatest with a complete cytoreduction.
While there is limited data on the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to CRS, a meta-analysis analyzing all available data concluded that there is likely a survival benefit of CRS/HIPEC, especially in the first 1-2 years, compared to CRS alone. Recommendations for CRS/HIPEC in this population are currently based on ovarian cancer guidelines.
Arm yourself—and your loved ones—with the information that matters.
Even the most proactive patients and advocates can only act on what they know. Help us spread the word about endometrial cancer!
Share knowledge | Share hope
We are Stronger Together!
